Novartis AG 2Q 2016 - Forecast
July 15 2016 - 11:01AM
Dow Jones News
FRANKFURT--The following is a summary of analysts' forecasts for
Novartis AG (NVS) second-quarter results, based on a poll of six
analysts conducted by Dow Jones Newswires (figures in million
dollars, EPS in dollar, DPS and target price in Swiss francs,
according to IFRS). Earnings figures are scheduled to be released
July 19.
===
Net sales:
2nd Quarter -total -Pharma -Diovan -Gleevec -Lucentis
AVERAGE 12,152 8,092 260 734 463
Prev. Year 12,694 8,633 333 1,184 537
+/- in % -4.3 -6.3 -22 -38 -14
MEDIAN 12,153 8,113 251 779 467
Maximum 12,285 8,195 292 815 479
Minimum 12,027 7,947 235 474 435
Amount 6 6 6 6 6
Cowen and Company 12,285 8,055 235 815 435
Deutsche Bank 12,174 8,126 292 776 467
Jefferies 12,075 8,128 244 772 466
Morgan Stanley 12,221 8,195 255 781 479
Vontobel 12,131 8,100 287 788 469
Zuercher KB 12,027 7,947 246 474 462
Core:
-Operating -Net attrib.
2nd Quarter income profit -EPS
AVERAGE 3,240 2,793 1.19
Prev. Year 3,593 3,074 1.27
+/- in % -9.8 -9.2 -6.2
MEDIAN 3,226 2,815 1.20
Maximum 3,370 2,858 1.20
Minimum 3,105 2,615 1.18
Amount 6 6 6
Cowen and Company 3,370 2,853 1.20
Deutsche Bank 3,211 2,806 1.18
Jefferies 3,210 2,799 1.18
Morgan Stanley 3,241 2,615 1.19
Vontobel 3,305 2,858 1.20
Zuercher Kantonalbank 3,105 2,824 1.20
Target price Rating DPS 2016
AVERAGE 89.50 positive 3 AVERAGE 2.80
Prev. Quarter 84.17 neutral 3 Prev. Year 2.70
+/- in % +6.3 negative 1 +/- in % +3.9
MEDIAN 83.50 MEDIAN 2.80
Maximum 115.00 Maximum 2.90
Minimum 75.00 Minimum 2.70
Amount 6 Amount 5
Cowen and Company 115.00 Outperform 2.90
Deutsche Bank 85.00 Hold --
Independent Research 82.00 Hold --
Jefferies 105.00 Buy 2.70
Morgan Stanley 75.00 Underweight 2.87
Vontobel 75.00 Hold 2.80
Zuercher Kantonalbank -- Overweight 2.75
===
Year-earlier figures are as reported by the company - continued
operations.
DJG/voi
(END) Dow Jones Newswires
July 15, 2016 10:46 ET (14:46 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Sep 2023 to Sep 2024